Market Snapshot

BSE Sensex: 81118.6 -0.70%
BSE 500: 35946.69 -0.57%
BSE 200: 11252.01 -0.61%
BSE 100: 25940.81 -0.65%
BSE MidCap: 45681.28 -0.32%
BSE SmallCap: 53370.29 -0.30%
BSE BANKEX: 62570.44 -1.01%
BSE IT: 37839.04 -0.09%
Nifty 50: 24718.6 -0.68%
Nifty 500: 22906.2 -0.61%
Nifty 200: 13825.4 -0.65%
Nifty 100: 25331.35 -0.71%
Nifty Midcap 100: 58227.45 -0.37%
Nifty Small 100: 18374.8 -0.49%
Nifty IT: 38469.25 0.02%
Nifty PSU Bank: 6934.85 -1.18%

News:

Lemon Tree Hotels signs new pr...
Adani Enterprises arm incorpor...
Syngenes Bengaluru-based facil...
NATCO Pharmas Hyderabad-based ...
Arkade Developers acquires 6.2...

Everest Organics Ltd Share Price – BSE
Pharmaceuticals, Small Cap

Invest

13 Jun 2025 | 03:59 PM

402.50

-21.15 (-4.99%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

182.95%

Return (1Y)

Beaten BSE Sensex by 177.34%
More Volatile

3.81%

Standard Deviation (1Y)

Higher than BSE Sensex by 2.97%
Not so consistent

6/12

Months

underperformed BSE Sensex
AxisDirect View

No View

52 Week High-Low

477

112

News & Announcements

Everest Organics standalone net profit rises 4750.00% in the March 2025 quarter

17 days ago

Everest Organics schedules board meeting
24 days ago

Everest Organics schedules board meeting

22 - May - 2025 12:00 | 24 days ago

Everest Organics will hold a meeting of the Board of Directors of the Company on 27 May 2025.
Powered by Capital Market - Live News
Everest Organics hits the roof after securing KDMF nod for Rabeprazole Sodium API
117 days ago

Everest Organics hits the roof after securing KDMF nod for Rabeprazole Sodium API

18 - Feb - 2025 12:00 | 117 days ago

The Rabeprazole Sodium API is primarily used to treat conditions related to excessive stomach acid production, including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, as it acts as a proton pump inhibitor (PPI) by significantly reducing the amount of acid produced in the stomach, essentially helping to heal ulcers and alleviate symptoms like heartburn and acid reflux.
According to the regulatory filing, the company revealed that the approval, granted in February 2025, allows it to export its Rabeprazole Sodium API to the South Korean market.
Everest Organics is engaged in the manufacturing of active pharmaceutical ingredients and bulk drugs.
The company's standalone net profit surged to Rs 1.14 crore in Q3 FY25 as against Rs 0.02 crore posted in Q3 FY24. However, revenue from operations fell 19.9% YoY to Rs 42.05 crore in the quarter ended 31 December 2024.
Powered by Capital Market - Live News
Everest Organics standalone net profit rises 5600.00% in the December 2024 quarter
123 days ago

Everest Organics standalone net profit rises 5600.00% in the December 2024 quarter

12 - Feb - 2025 12:00 | 123 days ago

Net profit of Everest Organics rose 5600.00% to Rs 1.14 crore in the quarter ended December 2024 as against Rs 0.02 crore during the previous quarter ended December 2023. Sales declined 19.92% to Rs 42.05 crore in the quarter ended December 2024 as against Rs 52.51 crore during the previous quarter ended December 2023.
Particulars Quarter Ended
Dec. 2024 Dec. 2023 % Var.
Sales 42.05 52.51 -20
OPM % 9.56 5.35 -
PBDT 2.62 1.49 76
PBT 1.15 0.16 619
NP 1.14 0.02 5600
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Promoter shareholding in Everest Organics Ltd has decreased by -17.62% since past 1 Year
Everest Organics Ltd has opened at 402.5 i.e -4.99% below then yesterday's closing price of 423.65
Everest Organics Ltd has the Lowesr P/E ratio according to FY 202503 data among stocks in Pharmaceuticals Sector
Everest Organics Ltd has the Lowesr P/B ratio according to FY 202503 data among stocks in Pharmaceuticals Sector

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	40.93	52.62	-22	159.48	197.24	-19
OPM %	8.40	5.61	-	4.53	5.57	-
PBDT	2.51	2.01	25	2.72	6.41	-58
PBT	0.95	0.16	494	-3.24	0.61	PL
NP	2.91	0.06	4750	-1.29	0.14	PL

Particulars	Quarter Ended
	Dec. 2024	Dec. 2023	% Var.
Sales	42.05	52.51	-20
OPM %	9.56	5.35	-
PBDT	2.62	1.49	76
PBT	1.15	0.16	619
NP	1.14	0.02	5600

General Notifications

My Notifications

Research Notifications

Everest Organics Ltd Share Price – BSE Pharmaceuticals, Small Cap

402.50 -21.15 (-4.99%)

News & Announcements

Price vs Volume

Stock Trivia

Everest Organics Ltd Share Price – BSE
Pharmaceuticals, Small Cap

402.50

-21.15 (-4.99%)